Evidence map›Paper›PMID 8777733›Full record

ArticleHistochemistry and cell biology1995

Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neural markers.

W Härtig, G Brückner, M Holzer, K Brauer, V Bigl

Abstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

W HärtigDepartment of Neurochemistry, University of Leipzig, Germany.
G Brückner
M Holzer
K Brauer
V Bigl
Leipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study extends the application of the digoxigenin-anti-digoxigenin (DIG) technique to immunocytochemistry by using digoxigenin-tagged primary antibodies. Certain features of this technique when applied to non-radioactive in situ hybridization, such as the absence of endogeneous digoxigenin immunoreactivity in animal tissues, seem to be advantageous also for its application to immunocytochemistry. Thus, the present work is focused on dual-peroxidase staining experiments based on digoxigenylated antibodies directed against glial fibrillary acidic protein, parvalbumin, and calbindin, in a straightforward combination with conventional cytochemical methods. The protocols include the concomitant detection of two antigens, for which only primary antibodies from one animal species are available, with differently haptenized antibodies (e.g., biotinylated anti-calbindin and digoxigenylated anti-parvalbumin). The versatility of the DIG technique is exemplified by the combination of lectin and immunocytochemical procedures for the detection of astrocytes and microglia, and the simultaneous visualization of perineuronal nets and parvalbumin-containing neurons in the rat brain.

Indexed as

AnimalsAntibodies, MonoclonalAntibody FormationAstrocytesBiomarkersBrainBrain ChemistryCalbindinsDigoxigeninExtracellular MatrixGlial Fibrillary Acidic ProteinImmunoenzyme TechniquesImmunohistochemistryMiceMicrogliaNeuronsAntibodies, MonoclonalBiomarkersCalbindinsDigoxigeninGlial Fibrillary Acidic ProteinParvalbuminsS100 Calcium Binding Protein G

Identifiers

PMID8777733
OpenAlexW1985373339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.